Bioelectric Medicine Market 7.2% CAGR Find Out Growth Potential Through Demand Forecast 2026 | CMI
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Get Sample PDF (Including COVID-19 Impact Analysis, Full TOC, Tables and Figures) of Bioelectric Medicine, https://www.coherentmarketinsights.com/insight/request-pdf/1757
Global Bioelectric Medicine Market, by Product Type (Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Other Bioelectric Medicines), by Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson’s Disease, Tremor, Depression, Epilepsy, Urinary, and Fecal Incontinence, and Others), By End User (Hospitals, Ambulatory Care Centers, and Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 12.3 billion in 2017, and is estimated to exhibit a CAGR of 7.2% over the forecast period (2018-2026), as highlighted in a new report published by Coherent Market Insights.
Key players in the global bioelectric medicine market are focusing on adopting mergers and acquisitions strategies, in order to strengthen their market position. For instance, GlaxoSmithKline completed a merger with Google’s parent company Alphabet to set up a new bioelectric company called Galvani Bioelectronics to develop bioelectric medicines in 2016. Furthermore, GlaxoSmithKline invested around US$ 615 million for the development of Galvani Bioelectronics Company, in 2016. Similarly, in 2015, Synapse Electroceutical Technology launched Accel-Heal, which is a non-invasive class 2A medical device. The device promotes healing of leg ulcers by using electrical energy. Accel-Heal delivers a sequence of low level, pre-programmed, and sub sensory electrical energy through surface of the skin.
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1757
Moreover, increasing number of investments for the development of advanced bioelectric medicine is another major factor that is expected to drive the market growth over the forecast period. For instance, according to press release of GlaxoSmithKline, GSK invested US$ 50 million in a start-up company called Set Point in 2013, which is engaged in the development of implantable devices that would stimulate the vagus nerve in the neck with electrical impulses to treat epilepsy and depression.
Additionally, ElectroCore, Inc., a U.S.-based company, offers devices in global bioelectric medicine market, such as gammaCore. This is non-invasive vagus nerve stimulator that provides a mild electrical stimulation to the vagus nerve and runs through the neck and carries information to the central nervous system. Moreover, each stimulation with gammaCore lasts 2 minutes and delivers up to 30 stimulations in a 24-hour period. This device is utilized for the treatment of migraine or cluster headache pain.
Browse 35 Market Data Tables and 23 Figures spread through 180 Pages and in-depth TOC on “Bioelectric Medicine Market”, by Product Type (Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Other Bioelectric Medicines), by Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson’s Disease, Tremor, Depression, Epilepsy, Urinary and Fecal Incontinence, and Others), by End User (Hospitals, Ambulatory Care Centers, and Diagnostic Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026”
To know the latest trends and insights related Global Bioelectric Medicine Market Press Release, click the link below: https://bit.ly/33pOmHe
Key Takeaways of the Global Bioelectric Medicine Market:
- The global bioelectric medicine market is expected to exhibit a CAGR of 7.2% over the forecast period (2018-2026), attributed to increasing number mergers and acquisitions and advancements in technology by key players
- Among product type, implantable cardioverter defibrillators segment is expected to account for major market share, in terms of revenue in 2026. This is attributed to increasing application of these products for the treatment of arrhythmia. For instance, according to the Centers for Disease Control and Prevention (CDC), around 2.7-6.1 million people in the U.S. had arrhythmia, in 2017.
- Key players operating in the global bioelectric medicine market include GlaxoSmithKline, Medtronic Plc., Boston Scientific Corporation, Liva Nova Plc, Electrocore, Nevro, and St. Jude Medical.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire